It’s six years since Europe led the way and created a regulatory framework for approving generic versions of biopharmaceuticals, or biosimilars. Now similar legislation has been enacted in the US
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.